Financial Performance Expectations - The company expects a net profit attributable to shareholders for the first half of 2024 to be between 38 million and 56 million CNY, a decrease of 55.62 million to 73.62 million CNY compared to the same period last year, representing a year-on-year decline of 49.83% to 65.96%[2] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 30 million and 45 million CNY, down by 56.70 million to 71.70 million CNY year-on-year, reflecting a decrease of 55.75% to 70.50%[3] - The total profit for the same period last year was 139.10 million CNY, with a net profit attributable to shareholders of 111.62 million CNY[4] Factors Affecting Performance - The decline in performance is primarily attributed to weak cement demand, intense market competition, and a decrease in sales and prices of cement products, leading to lower revenue and gross margin[5] - Sales of pharmaceutical products also declined, with intensified competition in intermediates and pesticide markets, resulting in lower sales prices and gross margin[5] Financial Reporting and Estimates - The financial data includes preliminary estimates from joint ventures, which may introduce uncertainty and potential discrepancies with the final disclosed performance data[6] - The company emphasizes that the forecasted data is preliminary and the accurate financial figures will be disclosed in the official 2024 semi-annual report[7]
尖峰集团(600668) - 2024 Q2 - 季度业绩预告